D.C. Mun. Regs. tit. 17, r. 17-10099
As used in this chapter, the following terms have the meanings ascribed:
Act - the Collaborative Care Expansion Amendment Act of 2012, effective October 22, 2012 (D.C. Law 19-0185; 60 DCR 7591 (May 31, 2013)).
Collaborative practice agreement- means a voluntary written agreement between a licensed pharmacist and a licensed physician that has been approved by the Board of Pharmacy and the Board of Medicine, or between a licensed pharmacist and another health practitioner with independent prescriptive authority licensed by a District health occupation board, that defines the scope of practice between the licensed pharmacist and licensed physician, or other health practitioner, for the initiation, modification, or discontinuation of a drug therapy regimen.
Institutional facility- means any organization whose primary purpose is to provide a physical environment for patients to obtain health care services, including a(n):
Institutional facility practice protocol - means a written plan, policy, procedure, or agreement that authorizes drug therapy management between pharmacists and physicians within an institutional facility setting as developed and determined by the institutional facility's P and T Committee, the institutional facility's medical staff executive committee, or the institutional facility's medical director.
Physician- a person holding a degree in medicine (MD) or osteopathy (DO).
Standard of Care- the course of action that other prudent and well- trained health professionals in the same field of practice would customarily take under the same or similar circumstances.
D.C. Mun. Regs. tit. 17, r. 17-10099